Fannie Mae, Freddie Mac shares tumble after conservatorship comments
Pamela Thomas-Graham, a director at Compass , Inc. (NYSE:COMP), recently executed a series of stock transactions, according to a filing with the Securities and Exchange Commission. On February 19, Thomas-Graham sold 35,683 shares of Compass Class A Common Stock, realizing a total of approximately $321,200. The shares were sold at a weighted average price of $9.0015, with individual transactions ranging from $9.00 to $9.02 per share. The timing of these transactions coincides with Compass’s strong market performance, with the stock up 180% over the past year and trading near its 52-week high of $10.25.
In a related transaction on the same day, Thomas-Graham exercised stock options to acquire 26,872 shares at a price of $6.44 per share, totaling $173,055. This option exercise was part of an automatic stock option plan adopted on May 10, 2024. According to InvestingPro analysis, Compass, currently valued at $5 billion, is expected to turn profitable this year, with analysts projecting positive earnings.
Following these transactions, Thomas-Graham holds 93,990 shares of Compass stock directly. These transactions were conducted under a Rule 10b5-1 trading plan, which allows insiders to set up a predetermined plan to sell company stock in accordance with insider trading laws. For deeper insights into Compass’s valuation and 17 additional key investment tips, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Compass Inc. has seen several analysts adjust their outlooks on the company following its financial performance and strategic moves. UBS analyst Chris Kuntarich raised the price target for Compass to $12.00, citing stronger-than-anticipated first-quarter guidance and strategic acquisitions, including Christie’s. UBS also maintains a Buy rating, expecting Compass’s EBITDA to potentially triple from FY24 to FY26. Similarly, Needham analysts increased their price target to $12.00, highlighting the successful integration of Christie’s and the impact of Compass’s three-phase marketing strategy.
Morgan Stanley (NYSE:MS) also revised its price target upwards to $8.50, acknowledging Compass’s strong operational execution and effective cost management despite challenges in the real estate market. Oppenheimer’s Jason Helfstein lifted the price target to $12.00, driven by positive management commentary and a favorable fourth-quarter pre-announcement that exceeded revenue and EBITDA expectations. Helfstein also noted the potential impact of changes in the "Clear Cooperation" policy, which could enhance the value of Compass’s listings.
These developments reflect a consensus among analysts that Compass’s strategic initiatives and financial performance are positioning the company for potential growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.